Fundus Camera Module for Early Detection of Alzheimer's Disease

Recruiting now

Conditions studied: Alzheimer Disease

In brief

Alzheimer's Disease (AD) affects tens of millions of people just in Europe. It is typically detected in its late stage when irreversible damage has already occurred, and current treatments are mostly conservative or palliative. Here we developed a device performing high-resolution multispectral imaging of the eye fundus to detect AD in its early stage. After clinical testing, the proposed device has a high potential to become a method for routine population screening, as it is non-invasive and affordable. The possibility of AD detection in an early stage is crucial for developing a new pharmaceutical treatment that would dramatically improve the lives of millions and save the expenses connected to lifelong healthcare assistance to people with AD in later stages.

Key facts

Study ID
NCT06841848
Run by
I.R.C.C.S. Fondazione Santa Lucia
People needed
80
Starts
2023-05-01
Expected to finish
2026-03-01
Last updated by the study team
2025-02-24

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.